반응식
[CH:1]1[N:6]=[C:5](Cl)[C:4]2[N:8]=[CH:9][N:10]([C@@H:11]3[O:15][C@H:14]([CH2:16][OH:17])[C@@H:13]([OH:18])[C@H:12]3[OH:19])[C:3]=2[N:2]=1.[S:20]1[CH:24]=[C:23]([CH2:25][CH2:26][NH2:27])[C:22]2[CH:28]=[CH:29][CH:30]=[CH:31][C:21]1=2.Cl.C(N(CC)CC)C>>[S:20]1[CH:24]=[C:23]([CH2:25][CH2:26][NH:27][C:5]2[C:4]3[N:8]=[CH:9][N:10]([C:3]=3[N:2]=[CH:1][N:6]=2)[C@@H:11]2[O:15][C@H:14]([CH2:16][OH:17])[C@@H:13]([OH:18])[C@H:12]2[OH:19])[C:22]2[CH:28]=[CH:29][CH:30]=[CH:31][C:21]1=2참가 물질
5
실험 절차
The title compound was prepared as in Example 1 using 6-chloropurine riboside (1.15 g, 4 mmol), 2-(3-benzo[b]thienyl)ethylamine.HCl (CAS Number 148585-66-1) (1.0 g, 4.6 mmol), and triethylamine (1.1 g, 11 mmol); yield 1.5 g (88%), mp 173°-174° C.
출처 및 근거
- ORD 기록
- ord-538156a5d0284b33a2ca6d409eeece17
- 출처 데이터셋
- uspto-grants-1988_08
- 특허 번호
- US04764506
연결된 노트
불러오는 중…